[When Doctors Without Borders writes to Miles White, chairman of Abbott Laboratories].
Nau
Jean-Yves
JY
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D003906:Developing Countries; D004338:Drug Combinations; D004345:Drug Industry / Q000941:ethics*; D017320:HIV Protease Inhibitors / Q000600:supply & distribution*; D006801:Humans; D007390:International Agencies; D061466:Lopinavir; D011744:Pyrimidinones / Q000600:supply & distribution*; D019438:Ritonavir / Q000600:supply & distribution*
D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir